Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of torsemide versus furosemide in heart failure patients: A systematic review of randomized controlled trials.
Ahmad Cheema H, Azeem S, Ejaz A, Khan F, Muhammad A, Shahid A, Nashwan AJ, Maqsood MH, Dani SS, Mentz RJ, Fudim M, Fonarow GC. Ahmad Cheema H, et al. Among authors: mentz rj. Clin Cardiol. 2024 Jan;47(1):e24088. doi: 10.1002/clc.24088. Epub 2023 Aug 22. Clin Cardiol. 2024. PMID: 37608566 Free PMC article. No abstract available.
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
Greene SJ, Vaduganathan M, Lupi L, Ambrosy AP, Mentz RJ, Konstam MA, Nodari S, Subacius HP, Fonarow GC, Bonow RO, Gheorghiade M; EVEREST Trial Investigators. Greene SJ, et al. Among authors: mentz rj. Am J Cardiol. 2013 Feb 15;111(4):574-81. doi: 10.1016/j.amjcard.2012.10.042. Epub 2012 Dec 1. Am J Cardiol. 2013. PMID: 23206923 Clinical Trial.
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
Butler J, Subacius H, Vaduganathan M, Fonarow GC, Ambrosy AP, Konstam MA, Maggioni A, Mentz RJ, Swedberg K, Zannad F, Gheorghiade M; EVEREST Investigators. Butler J, et al. Among authors: mentz rj. J Am Coll Cardiol. 2013 Feb 5;61(5):571-9. doi: 10.1016/j.jacc.2012.10.025. Epub 2012 Dec 12. J Am Coll Cardiol. 2013. PMID: 23246389 Free article. Clinical Trial.
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).
Vaduganathan M, Greene SJ, Ambrosy AP, Mentz RJ, Fonarow GC, Zannad F, Maggioni AP, Konstam MA, Subacius HP, Nodari S, Butler J, Gheorghiade M; EVEREST Trial Investigators. Vaduganathan M, et al. Among authors: mentz rj. Am J Cardiol. 2013 Dec 1;112(11):1763-9. doi: 10.1016/j.amjcard.2013.07.020. Epub 2013 Oct 4. Am J Cardiol. 2013. PMID: 24095030 Free PMC article.
Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).
Vaduganathan M, Dei Cas A, Mentz RJ, Greene SJ, Khan S, Subacius HP, Chioncel O, Maggioni AP, Konstam MA, Senni M, Fonarow GC, Butler J, Gheorghiade M; EVEREST Trial Investigators. Vaduganathan M, et al. Among authors: mentz rj. Am J Cardiol. 2014 Sep 1;114(5):743-50. doi: 10.1016/j.amjcard.2014.05.064. Epub 2014 Jun 24. Am J Cardiol. 2014. PMID: 25060414 Free PMC article. Clinical Trial.
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.
Greene SJ, Shah AN, Butler J, Ambrosy AP, Anker SD, Chioncel O, Collins SP, Dinh W, Dunnmon PM, Fonarow GC, Lam CS, Mentz RJ, Pieske B, Roessig L, Rosano GM, Sato N, Vaduganathan M, Gheorghiade M. Greene SJ, et al. Among authors: mentz rj. Am Heart J. 2014 Aug;168(2):142-9. doi: 10.1016/j.ahj.2014.05.009. Epub 2014 May 24. Am Heart J. 2014. PMID: 25066552 Free PMC article.
547 results